Abstract
PTH is a major regulator of calcium homeostasis by mobilizing calcium through bone resorption. We show that the expression of collagenase-3 (MMP-13), a member of the family of matrix metalloproteinases, required for the cleavage of collagens in the bone, is increased upon PTH injection in mice. A cis-acting element in the collagenase-3 promoter was identified which, together with AP-1, is required for induction by PTH. This element contains CCACA motifs which are required for binding of the 65 kDa osteoblast-specific splice variant of Cbfa1. Introduction of mutations in this binding site that interfere with protein interaction also eliminates PTH inducibilty and transactivation by Cbfa/Runt proteins. While DNA binding activity of AP-1 is increased upon PTH treatment, high basal level of Cbfa/Runt binding activity is detectable in untreated cells which is not further increased by PTH, suggesting that AP-1 and Cbfa1 contribute to transcriptional activation through different mechanisms. In agreement with the critical role of both proteins defined in tissue culture cells, expression of collagenase-3 is reduced in mice lacking c-fos and is completely absent in cbfa1−/− embryos. These data provide the first evidence for a critical role of Cbfa1, a major regulator of bone development, in PTH-dependent processes such as bone resorption.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout






Similar content being viewed by others
References
Abou-Samra AB, Juppner H, Westerberg D, Potts Jr JT and Segre GV. . 1989 Endocrinology 124: 1107–1113.
Angel P, Baumann I, Stein B, Delius H, Rahmsdorf HJ and Herrlich P. . 1987a Mol. Cell. Biol. 7: 2256–2266.
Angel P, Imagawa M, Chiu R, Stein B, Imbra RJ, Rahmsdorf HJ, Jonat C, Herrlich P and Karin M. . 1987b Cell 49: 729–739.
Angel P, Hattori K, Smeal T and Karin M. . 1988 Cell 55: 875–885.
Angel P and Karin M. . 1991 Biochim. Biophys. Acta 1072: 129–157.
Bae SC, Yamaguchi Iwai Y, Ogawa E, Maruyama M, Inuzuka M, Kagoshima H, Shigesada K, Satake M and Ito Y. . 1993 Oncogene 8: 809–814.
Chomczynski P and Sacchi N. . 1987 Anal. Biochem. 162: 156–159.
Clohisy JC, Scott DK, Brakenhoff KD, Quinn CO and Partridge NC. . 1992 Mol. Endocrinol. 6: 1834–1842.
Dignam JD, Lebovitz RM and Roeder RG. . 1983 Nucleic Acids Res. 11: 1475–1489.
Ducy P and Karsenty G. . 1995 Mol. Cell. Biol. 15: 1858–1869.
Ducy P, Zhang R, Geoffroy V, Ridall AL and Karsenty G. . 1997 Cell 89: 747–754.
Evans DB, Hipskind RA and Bilbe G. . 1996 J. Bone Miner. Res. 11: 1066–1074.
Freije JM, Diez Itza I, Balbin M, Sanchez LM, Blasco R, Tolivia J and Lopez Otin C. . 1994 J. Biol. Chem. 269: 16766–16773.
Gack S, Vallon R, Schaper J, Rüther U and Angel P. . 1994 J. Biol. Chem. 269: 10363–10369.
Gack S, Vallon R, Schmidt J, Grigoriadis A, Tuckermann J, Schenkel J, Weiher H, Wagner EF and Angel P. . 1995 Cell Growth and Diff. 6: 759–767.
Geoffroy V, Ducy P and Karsenty G. . 1995 J. Biol. Chem. 270: 30973–30979.
Grigoriadis AE, Wang ZQ and Wagner EF. . 1995 Trends Genet. 11: 436–441.
Gutman A and Wasylyk B. . 1990 EMBO. J. 9: 2241–2246.
Heath JK, Atkinson SJ, Meikle MC and Reynolds JJ. . 1984 Biochim. Biophys. Acta 802: 151–154.
Henriet P, Rousseau GG and Eeckhout Y. . 1992 FEBS. Lett. 310: 175–178.
Hu E, Mueller E, Oliviero S, Papaioannou VE, Johnson R and Spiegelman BM. . 1994 EMBO. J. 13: 3094–3103.
Juppner H, Abou Samra AB, Freeman M, Kong XF, Schipani E, Richards J, Kolakowski Jr LF, Hock J, Potts Jr JT, Kronenberg HM and Segre GV. . 1991 Science 254: 1024–1026.
Kamachi Y, Ogawa E, Asano M, Ishida S, Murakami Y, Satake M, Ito Y and Shigesada K. . 1990 J. Virol. 64: 4808–4819.
Karaplis AC, Luz A, Glowacki J, Bronson R T, Tybulewicz VL, Kronenberg HM and Mulligan RC. . 1994 Genes Dev. 8: 277–289.
Knäuper V, Lopez Otin C, Smith B, Knight G and Murphy G. . 1996 J. Biol. Chem. 271: 1544–1550.
Komori T, Yagi H, Nomura S, Yamagushi A, Sasaki K, Degushi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S and Kishimoto T. . 1997 Cell 89: 755–764.
Kronenberg HM. . 1996 Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 3rd Edition. Murray MD and Favus J. (eds.) Lippincott-Raven: New York pp. 68–70.
Kryszke MH, Piette J and Yaniv M. . 1987 Nature 328: 254–256.
Lanske B, Karaplis AC, Lee K, Luz A, Vortkamp A, Pirro A, Karperien M, Defize LHK, Ho C, Mulligan RC, Abou Samra AB, Juppner H, Segre GV and Kronenberg HM. . 1996 Science 273: 663–666.
Luckow B and Schütz G. . 1987 Nucleic Acids Res. 15: 5490.
Mattot V, Raes MB, Henriet P, Eeckhout Y, Stehelin D, Vandenbunder B and Desbiens X. . 1995 J. Cell. Sci. 108: 529–535.
Minden A and Karin M. . 1997 Biochim. Biophys. Acta 1333: F85–F104.
Miyoshi H, Ohira M, Shimizu K, Mitani K, Hirai H, Imai T, Yokoyama K, Soeda E and Ohki M. . 1995 Nucleic Acids Res. 23: 2762–2769.
Ogawa E, Inuzuka M, Maruyama M, Satake M, Naito Fujimoto M, Ito Y and Shigesada K. . 1993a Virology 194: 314–331.
Ogawa E, Maruyama M, Kagoshima H, Inuzuka M, Lu J, Satake M, Shigesada K and Ito Y. . 1993b Proc. Natl. Acad. Sci. USA 90: 6859–6863.
Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GW, Beddington RS, Mundlos S, Olsen BR, Selby PB and Owen MJ. . 1997 Cell 89: 765–771.
Pearman AT, Chou WY, Bergman KD, Pulumati MR and Partridge NC. . 1996 J. Biol. Chem. 271: 25715–25721.
Pendas AM, Knäuper V, Puente XS, Llano E, Mattei MG, Apte S, Murphy G and Lopez Otin C. . 1997 J. Biol. Chem. 272: 4281–4286.
Pollock JH, Blaha MJ, Lavish SA, Stevenson S and Greenfield EM. . 1996 J. Bone Miner. Res. 11: 754–759.
Quinn CO, Scott DK, Brinckerhoff CE, Matrisian LM, Jeffrey JJ and Partridge NC. . 1990 J. Biol. Chem. 265: 22342–22347.
Rajakumar RA and Quinn CO. . 1996 Mol. Endocrinol. 10: 867–878.
Satake M, Ibaraki T and Ito Y. . 1988 Oncogene 3: 69–78.
Schipani E, Kruse K and Juppner H. . 1995 Science 268: 98–100.
Schorpp M, Mattei MG, Herr I, Gack S, Schaper J and Angel P. . 1995 Biochem. J. 308: 211–217.
Schreiber M, Baumann B, Cotten M, Angel P and Wagner EF. . 1995 EMBO. J. 14: 5338–5349.
Scott DK, Brakenhoff KD, Clohisy JC, Quinn CO and Partridge NC. . 1992 Mol. Endocrinol. 6: 2153–2159.
Shalhoub V, Conlon D, Tassinari M, Quinn C, Partridge N, Stein GS and Lian JB. . 1992 J. Cell. Biochem. 50: 425–440.
Smeal T, Hibi M and Karin M. . 1994 EMBO. J. 13: 6006–6010.
Tanaka T, Kurokawa M, Ueki K, Tanaka K, Imai Y, Mitani K, Okazaki K, Sagata N, Yazaki Y, Shibata Y, Kadowaki T and Hirai H. . 1996 Mol. Cell. Biol. 16: 3967–3979.
van Dam H, Wilhelm D, Herr I, Steffen A, Herrlich P and Angel P. . 1995 Embo. J. 14: 1798–1811.
Wang ZQ, Ovitt C, Grigoriadis AE, Möhle-Steinlein U, Rüther U and Wagner EF. . 1992 Nature 360: 741–745.
Yang R and Gerstenfeld LC. . 1996 J. Biol. Chem. 271: 29839–29846.
Yu XP and Chandrasekhar S. . 1997 Endocrinology 138: 3085–3092.
Zaiman AL and Lenz J. . 1996 J. Virol 70: 5618–5629.
Acknowledgements
We thank NC Partridge for sharing unpublished data on the rat MMP-13 promoter and for the rat cDNA library from osteosarcoma cells, S Gack for initial analysis of c-fos−/− embryos, and EF Wagner for c-fos knockout mice. We are grateful to N Keon for critical reading of the manuscript and to I Herr for help in performing UV cross-linking analysis. This work was supported by grants from the Deutsche Forschungsgemeinschaft (An 182/6-2) and the Training and Mobility of Researchers Programme of the European Community (ERBFMBICT961818), and by a PhD fellowship from the Boehringer Ingelheim Fonds.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Porte, D., Tuckermann, J., Becker, M. et al. Both AP-1 and Cbfa1-like factors are required for the induction of interstitial collagenase by parathyroid hormone. Oncogene 18, 667–678 (1999). https://doi.org/10.1038/sj.onc.1202333
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1202333
Keywords
This article is cited by
-
Runx2, an inducer of osteoblast and chondrocyte differentiation
Histochemistry and Cell Biology (2018)
-
Deletion of Runx2 in Articular Chondrocytes Decelerates the Progression of DMM-Induced Osteoarthritis in Adult Mice
Scientific Reports (2017)
-
Kruppel-like factor 4 expression in osteoblasts represses osteoblast-dependent osteoclast maturation
Cell and Tissue Research (2014)
-
Regulation of bone development and extracellular matrix protein genes by RUNX2
Cell and Tissue Research (2010)